184 related articles for article (PubMed ID: 31199785)
1. Convergent genetic aberrations in murine and human T lineage acute lymphoblastic leukemias.
Huang BJ; Wandler AM; Meyer LK; Dail M; Daemen A; Sampath D; Li Q; Wang X; Wong JC; Nakitandwe J; Downing JR; Zhang J; Taylor BS; Shannon K
PLoS Genet; 2019 Jun; 15(6):e1008168. PubMed ID: 31199785
[TBL] [Abstract][Full Text] [Related]
2. Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents.
Dail M; Li Q; McDaniel A; Wong J; Akagi K; Huang B; Kang HC; Kogan SC; Shokat K; Wolff L; Braun BS; Shannon K
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5106-11. PubMed ID: 20194733
[TBL] [Abstract][Full Text] [Related]
3. Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia.
Oshima K; Khiabanian H; da Silva-Almeida AC; Tzoneva G; Abate F; Ambesi-Impiombato A; Sanchez-Martin M; Carpenter Z; Penson A; Perez-Garcia A; Eckert C; Nicolas C; Balbin M; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Gastier-Foster JM; Devidas M; Loh ML; Kirschner-Schwabe R; Palomero T; Rabadan R; Ferrando AA
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11306-11311. PubMed ID: 27655895
[TBL] [Abstract][Full Text] [Related]
4. Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapy.
Hähnel PS; Enders B; Sasca D; Roos WP; Kaina B; Bullinger L; Theobald M; Kindler T
Blood; 2014 Apr; 123(15):2355-66. PubMed ID: 24505083
[TBL] [Abstract][Full Text] [Related]
5. RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD.
Sakhdari A; Thakral B; Loghavi S; Kanagal-Shamanna R; Yin CC; Zuo Z; Routbort MJ; Luthra R; Medeiros LJ; Wang SA; Patel KP; Ok CY
Cancer Med; 2020 Feb; 9(3):849-858. PubMed ID: 31804006
[TBL] [Abstract][Full Text] [Related]
6. JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia.
Mansour MR; He S; Li Z; Lobbardi R; Abraham BJ; Hug C; Rahman S; Leon TE; Kuang YY; Zimmerman MW; Blonquist T; Gjini E; Gutierrez A; Tang Q; Garcia-Perez L; Pike-Overzet K; Anders L; Berezovskaya A; Zhou Y; Zon LI; Neuberg D; Fielding AK; Staal FJT; Langenau DM; Sanda T; Young RA; Look AT
J Exp Med; 2018 Jul; 215(7):1929-1945. PubMed ID: 29941549
[TBL] [Abstract][Full Text] [Related]
7. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
[TBL] [Abstract][Full Text] [Related]
8. An Mb1-Cre-driven oncogenic Kras mutation results in a mouse model of T-acute lymphoblastic leukemia/lymphoma with short latency and high penetrance.
Junco JJ; Chen T; Rashid R; Terrell M; Gant VU; Miller M; Rau R; Lacorazza HD; Rabin KR
Leukemia; 2021 Jun; 35(6):1777-1781. PubMed ID: 32918044
[No Abstract] [Full Text] [Related]
9. Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL.
Levinson AL; Tjoa K; Huang B; Meyer LK; Kim MO; Brady SW; Zhang J; Shannon K; Wandler AM
Blood Adv; 2023 Jul; 7(14):3479-3484. PubMed ID: 36897249
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy.
Ksionda O; Mues M; Wandler AM; Donker L; Tenhagen M; Jun J; Ducker GS; Matlawska-Wasowska K; Shannon K; Shokat KM; Roose JP
PLoS One; 2018; 13(5):e0193849. PubMed ID: 29799846
[TBL] [Abstract][Full Text] [Related]
11. ETV6 mutations in early immature human T cell leukemias.
Van Vlierberghe P; Ambesi-Impiombato A; Perez-Garcia A; Haydu JE; Rigo I; Hadler M; Tosello V; Della Gatta G; Paietta E; Racevskis J; Wiernik PH; Luger SM; Rowe JM; Rue M; Ferrando AA
J Exp Med; 2011 Dec; 208(13):2571-9. PubMed ID: 22162831
[TBL] [Abstract][Full Text] [Related]
12. Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia.
Wandler AM; Huang BJ; Craig JW; Hayes K; Yan H; Meyer LK; Scacchetti A; Monsalve G; Dail M; Li Q; Wong JC; Weinberg O; Hasserjian RP; Kogan SC; Jonsson P; Yamamoto K; Sampath D; Nakitandwe J; Downing JR; Zhang J; Aster JC; Taylor BS; Shannon K
Leukemia; 2020 Aug; 34(8):2025-2037. PubMed ID: 32066867
[TBL] [Abstract][Full Text] [Related]
13. Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemia.
Zhang J; Duan Y; Wu P; Chang Y; Wang Y; Hu T; Liu C; Chen X; Zong S; Chen X; Wu Y; Jin L; Lan Y; Liu X; Cheng X; Ding F; Li T; Chen X; Guo Y; Chen Y; Yang W; Zhang L; Zou Y; Cheng T; Zhu X; Zhang Y
Blood; 2024 Jan; 143(4):320-335. PubMed ID: 37801708
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of acute lymphoblastic leukemia.
Teitell MA; Pandolfi PP
Annu Rev Pathol; 2009; 4():175-98. PubMed ID: 18783329
[TBL] [Abstract][Full Text] [Related]
15. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutation of IL7R exon 6 in acute leukemias and solid cancers.
Kim MS; Chung NG; Kim MS; Yoo NJ; Lee SH
Hum Pathol; 2013 Apr; 44(4):551-5. PubMed ID: 23069254
[TBL] [Abstract][Full Text] [Related]
17. Activation of proto-oncogenes by disruption of chromosome neighborhoods.
Hnisz D; Weintraub AS; Day DS; Valton AL; Bak RO; Li CH; Goldmann J; Lajoie BR; Fan ZP; Sigova AA; Reddy J; Borges-Rivera D; Lee TI; Jaenisch R; Porteus MH; Dekker J; Young RA
Science; 2016 Mar; 351(6280):1454-1458. PubMed ID: 26940867
[TBL] [Abstract][Full Text] [Related]
18. NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia.
Kimura S; Seki M; Yoshida K; Shiraishi Y; Akiyama M; Koh K; Imamura T; Manabe A; Hayashi Y; Kobayashi M; Oka A; Miyano S; Ogawa S; Takita J
Cancer Sci; 2019 Feb; 110(2):784-794. PubMed ID: 30387229
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C.
Cannataro VL; Gaffney SG; Stender C; Zhao ZM; Philips M; Greenstein AE; Townsend JP
Oncogene; 2018 May; 37(18):2444-2455. PubMed ID: 29453361
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of Notch signaling and immune checkpoint blockade in a spontaneous, genetically heterogeneous mouse model of T-cell acute lymphoblastic leukemia.
Gao J; Van Meter M; Hernandez Lopez S; Chen G; Huang Y; Ren S; Zhao Q; Rojas J; Gurer C; Thurston G; Kuhnert F
Dis Model Mech; 2019 Sep; 12(9):. PubMed ID: 31399482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]